Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

Source:http://linkedlifedata.com/resource/pubmed/id/18838256

Download in:

View as

General Info

PMID
18838256